See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2024_Provectus_Biopharmaceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000315545, Provectus Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,364,797 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 12,020 |
| 3 | remainder_Assets | 72,026 |
| 4 | LiabilitiesCurrent | 9,016,895 |
| 5 | LiabilitiesNoncurrent | 25,299 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,687,936 |
| 9 | ResearchAndDevelopmentExpense | 1,710,579 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 690,428 |
| 12 | remainder_NetIncome | -199,938 |
| 13 | remainder_ComprehensiveNetIncome | -140,855 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,448,843 |
| 1 | Liabilities | 9,042,194 |
| 2 | Expenses | 3,398,515 |
| 3 | Revenues | 690,428 |
| 4 | StockholdersEquity | -7,593,351 |
| 5 | NetIncome | -2,908,025 |
| 6 | ComprehensiveNetIncome | -2,978,452 |
| 7 | BaseVar | 7,460,386 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.72 |
| 9 | EconomicCapitalRatio | 0.465 |